Analysts at Canaccord Genuity Group assumed coverage on shares of TriSalus Life Sciences (NASDAQ:TLSI – Get Free Report) in a report released on Thursday, MarketBeat.com reports. The brokerage set a “buy” rating and a $12.00 price target on the stock. Canaccord Genuity Group’s price objective would indicate a potential upside of 67.60% from the company’s […]
Deerfield Management Company L.P. Series C acquired a new stake in shares of TriSalus Life Sciences, Inc. (NASDAQ:TLSIW – Free Report) in the third quarter, HoldingsChannel reports. The institutional investor acquired 333,333 shares of the company’s stock, valued at approximately $127,000. Separately, Context Capital Management LLC purchased a new position in TriSalus Life Sciences in […]
Deerfield Management Company L.P. Series C bought a new stake in TriSalus Life Sciences, Inc. (NASDAQ:TLSIW – Free Report) in the 3rd quarter, according to its most recent filing with the SEC. The fund bought 333,333 shares of the company’s stock, valued at approximately $127,000. Separately, Context Capital Management LLC acquired a new position in […]
Deerfield Management Company L.P. Series C bought a new stake in TriSalus Life Sciences, Inc. (NASDAQ:TLSIW – Free Report) in the 3rd quarter, according to its most recent filing with the SEC. The fund bought 333,333 shares of the company’s stock, valued at approximately $127,000. Separately, Context Capital Management LLC acquired a new position in […]